Skip to main content

Researches Our research spans a wide range from basic organic synthesis, drug design and development, structure elucidation of newly synthesized compound and natural products. The research focuses on the following strategic Research Themes: Design and synthesis of new chemical entities. Computer aided drug design studies. Structure-Activity relationship studies. Combinatorial chemistry. Prod rugs developments. Analytical methods for bioavailability and metabolic studies. Research within these Themes is carried out in multidisciplinary groupings focused on the discovery of novel techniques and/or enhancement of the already existing ones. At the department of Medicinal Pharmacy, We have major national and international collaborative research projects and a significant output of research publications in high-ranking journals. Our academic collaborators include many Universities in USA, Canada, Japan, and a number of major European universities.

# Title Research Year
51 Novel 3-(Benzylidene)indolin-2-one Derivatives as Cyclin-Dependent Kinase (CDK) Inhibitors with Potential Anticancer Activity 2019
52 Novel 3-(Benzylidene)indolin-2-one Derivatives as Cyclin-Dependent Kinase (CDK) Inhibitors with Potential Anticancer Activity 2019
53 Novel 3-(Benzylidene)indolin-2-one Derivatives as Cyclin-Dependent Kinase (CDK) Inhibitors with Potential Anticancer Activity 2019
54 Novel 3-(Benzylidene)indolin-2-one Derivatives as Cyclin-Dependent Kinase (CDK) Inhibitors with Potential Anticancer Activity 2019
55 " Design, Synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine(cYY)mimics" 2018
56 " Design, Synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine(cYY)mimics" 2018
57 " Design, Synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine(cYY)mimics" 2018
58 Application of salting-out thin layer chromatography incomputational prediction of minimum inhibitory concentration andblood-brain barrier penetration of some selected fluoroquinolones 2018
59 Modified Lidocaine Derivatives as a Potential Inhibitors of Eosinophils 2018
60 Modified Lidocaine Derivatives as a Potential Inhibitors of Eosinophils 2018